The global interventional lung disease market is expected to grow at a significant CAGR during the forecast period (2021-2027). Interventional pulmonology has revolutionized the field of pulmonary (related to the lungs and breathing) medicine by providing the most advanced minimally invasive procedures to diagnose and treat both malignant and non-malignant disorders of the lungs and airways.
The use of advanced inert materials such as silicon coating is leading to advancements in devices, which is increasing the demand for interventional pulmonology devices. Advanced bronchoscopes have built upon the strengths of original bronchoscopes by increasing device versatility and ease of use in complex cases, which is driving a large replacement market. This transformation has led to a positive impact on the demand for interventional pulmonology.
The global interventional lung disease market analysis includes some of the key market players such as Boston Scientific, Olympus, FUJIFILM, Becton Dickinson and Company, Smiths Group, and Cook Medical, among others. To maintain a strong position in the market, these market players are adopting various strategic moves, such as product launches, partnerships, collaborations, and mergers and acquisitions.
Recent Developments:
Market Coverage
Competitive Landscape: Boston Scientific, Olympus, FUJIFILM, Becton Dickinson and Company, Smiths Group, and Cook Medical, among others.
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global Interventional Lung Disease Market by Segment
By Application
• Hospital
• Emergency Center
• Clinic
By Product Types
• Bronchoscopes
• Respiratory Endotherapy Devices
• ENB Systems
• Pleuroscopes
• Other
Global Interventional Lung Disease Market by Region
North America
Europe
Asia-Pacific
Rest of the World